Orthopaedics and Trauma
Volume 23, Issue 4 , Pages 240-247 , August 2009

(iii) The management of soft-tissue sarcomas

References 

  1. Coindre J-M. Grading of Soft Tissue Sarcomas. Arch Pathol Lab Med. 2006;130:1448–1453
  2. Zahm SH, Fraumeni JF. The epidemiology of soft tissue sarcoma. Semin Oncol. 1997;24(5):504–514
  3. Storm HH. Survival of adult patients with cancer of soft tissues or bone in Europe. European Journal of Cancer. 1998;34:2212–2217
  4. NICE . Guidance on Improving Cancer Services: Improving Outcomes for People with Sarcoma. The Manual. London: National Institute for Health and Clinical Excellence; 2006;
  5. NCCN . National Comprehensive Cancer Network Clinical Practice Guidlines in Oncology: Soft Tissue Sarcoma. V.2.2008. National Comprehensive Cancer Network; 2008;
  6. NICE . Clinical guidline 27: Referral guidelines for suspected cancer. London: National Institute for Health and Clinical Excellence.; 2005;
  7. Welker JA, Henshaw RM, Jelinek J, Shmookler BM, Malawer MM. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer. 2000;89(12):2677–2686
  8. WHO . International Statistical Classification of Diseases and Health Related Problems. Tenth Revision. (ICD-10) Second ed. Geneva: World Health Organization; 2005;
  9. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. International Journal of Cancer. 1984;33(1):37–42
  10. Greene FL, Page DL, Fleming ID, et al. In: American Joint Committee on CancerCancer Staging Manual  editors. 6th ed. New York, NY: Springer; 2002;
  11. Enneking WF, Spanier SS, Goodman MA. Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg Am. 1980;62(6):1027–1030
  12. Enneking WF, Spanier SS, Malawer MM. The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer. 1981;47(5):1005–1022
  13. Rydholm A, Rooser B. Surgical margins for soft-tissue sarcoma. J Bone Joint Surg Am. 1987;69(7):1074–1078
  14. Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clinical Orthopaedics & Related Research. 2004;419:165–172
  15. Gerrand CH, Wunder JS, Kandel RA, et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. Journal of Bone and Joint Surg [Br]. 2001;83-B:1149–1155
  16. Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities - prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Annals of Surgery. 1982;196(3):305–315
  17. Stojadinovic A, Leung DHY, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas. Annals of Surgery. 2002;235(3):424–434
  18. Brooks AD, Gold JS, Graham D, et al. Resection of the Sciatic, Peroneal, or Tibial Nerves: Assessment of Functional Status. Annals of Surgical Oncology. 2002;9(1):41–47
  19. Ghert MA, Davis AM, Griffin AM, et al. The Surgical and Functional Outcome of Limb-Salvage Surgery With Vascular Reconstruction for Soft Tissue Sarcoma of the Extremity. Ann Surg Oncol. 2005;12(12):1102–1110
  20. Davis AM, Sennik S, Griffin AM, et al. Predictors of functional outcomes following limb salvage surgery for lower-extremity soft tissue sarcoma. Journal of Surgical Oncology. 2000;73(4):206–211
  21. Pisters PWT, O'Sullivan B, Maki RG. Evidence-Based Recommendations for Local Therapy for Soft Tissue Sarcomas. J Clin Oncol. 2007;25(8):1003–1008
  22. Davis AM, Devlin M, Griffin AM, Wunder JS, Bell RS. Functional outcome in amputation verses limb sparing of patients with lower extremity sarcoma: a matched case-control study. Achives of Physical Medicine and Rehabilitation. 1999;80(6):615–618
  23. WHO. World Health Organization . International Classification of Functioning. Disability and Health (ICF). Geneva: World Health Organization; 2001;
  24. Parsons JA, Davis AM. Rehabilitation and Quality-of-Life Issues in Patients with Extremity Soft Tissue Sarcoma. Current Treatment Options in Oncology. 2004;5:477–488
  25. Davis AM. Functional outcome in extremity soft tissue sarcoma. Seminars in Radiation Oncology. 1999;9(4):360–368
  26. Gerrand CH, Wunder JS, Kandel RA, et al. The Influence of Anatomic Location on Functional Outcome in Lower-Extremity Soft-Tissue Sarcoma. Annals of Surgical Oncology. 2004;11(5):476–478
  27. Khanfir K, Alzieu L, Terrier P, et al. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?. European journal of cancer. 2003;39(13):1872–1880
  28. Yang JC, Chang AE, Baker AR, et al. Randomised Prospective Study of the Benefit of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcomas of the Extremity. Journal of Clinical Oncology. 1998;16:197–203
  29. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-Term Results of a Prospective Randomised Trial of Adjuvant Brachytherapy in Soft Tissue Sarcoma. Journal of Clinical Oncology. 1996;14:849–868
  30. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative verses postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. The Lancet. 2002;359:2235–2241
  31. Pitson G, Robinson P, Wilke D, et al. Radiation response: An additional unique signature of myxoid liposarcoma. International Journal of Radiation Oncology, Biology, Physics. 2004;60(2):522–526
  32. SMAC . Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Cochrane Database of Systematic Reviews. 2000;(Issue 4):
  33. SMAC . Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. The Lancet. 1997;350(9092):1647–1654
  34. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–581
  35. Judson I. State-of-the-art approach in selective curable tumours: soft tissue sarcoma. Annals of Oncology. 2008;19(Suppl 7):vii166–vii9
  36. DeLaney TF, Spiro IJ, Suit HD, et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. International Journal of Radiation Oncology, Biology, Physics. 2003;56(4):1117–1127
  37. Hohenberger P, Wysocki WM. Neoadjuvant Treatment of Locally Advanced Soft Tissue Sarcoma of the Limbs: Which Treatment to Choose?. Oncologist. 2008;13(2):175–186
  38. MacDougall RH, Kerr GR, Duncan W. Incidence of sarcoma in patients treated with fast neutrons. International Journal of Radiation Oncology, Biology, Physics. 2006;66(3):842–844
  39. Davis AM, O'Sullivan B, Bell RS, et al. Function and Health Status Outcomes in a Randomized Trial Comparing Preoperative and Postoperative Radiotherapy in Extremity Soft Tissue Sarcoma. J Clin Oncol. 2002;20(22):4472–4477
  40. Mitchell SY, Lingard EA, Kesteven P, McCaskie AW, Gerrand CH. Venous Thromboembolism in Patients with Primary Bone or Soft-Tissue Sarcomas. Journal of Bone and Joint Surg [Am]. 2007;89:2433–2439
  41. Gerrand CH, Billingham LJ, Woll PJ, Grimer RJ. Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom. Sarcoma. 2007;1–6
  42. Lord HK, Salter DM, MacDougall RH, Kerr GR. Is routine chest radiography a useful test in the follow up of all adult patients with soft tissue sarcoma?. Br J Radiol. 2006;79(946):799–800
  43. Stojadinovic A, Jaques DP, Leung DHY, Healey JH, Brennan MF. Amputation for Recurrent Soft Tissue Sarcoma of the Extremity: Indications and Outcome. Annals of Surgical Oncology. 2001;8(6):509–518
  44. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. Journal of Clinical Oncology. 1996;14:1679–1689
  45. Espat NJ, Lewis JJ. The biological significance of failure at the primary site on ultimate survival in soft tissue sarcoma. Seminars in Radiation Oncology. 1999;9(4):369–377
  46. Pearlstone DB, Janjan NA, Feig BW, et al. Re-resection with brachytherapy for locally recurrent soft tissue sarcoma in a previously irradiated field. Cancer J Sci Am. 1999;5(1):26–33
  47. Coindre J-M, Terrier P, Guillou L, et al. Predictive Value of Grade for Metastasis Development in the Main Histologic Types of Adult Soft Tissue Sarcomas. A Study of 1240 Patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91(10):1914–1926
  48. Kattan MW, Leung DHY, Brennan MF. Postoperative Nomogram for 12-Year Sarcoma-Specific Death. J Clin Oncol. 2002;20(3):791–796
  49. Rehders A, Hosch SB, Scheunemann P, Stoecklein NH, Knoefel WT, Peiper M. Benefit of Surgical Treatment of Lung Metastasis in Soft Tissue Sarcoma. Arch Surg. 2007;142(1):70–75
  50. Kasper B, Gil T, D'Hondt V, Gebhart M, Awada A. Novel treatment strategies for soft tissue sarcoma. Critical Reviews in Oncology/Hematology. 2007;62(1):9–15

PII: S1877-1327(09)00080-3

doi: 10.1016/j.mporth.2009.05.004

Orthopaedics and Trauma
Volume 23, Issue 4 , Pages 240-247 , August 2009

Article Tools

* Image Usage & Resolution